Insider Trading Activity - GOODMAN COREY S

Real time insider trading transaction history:

Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Trading Transactions for GOODMAN COREY S

Goto 0, 1, Next

Common stock purchase or sale:

Transaction Date	Reported DateTime	Company	Symbol	Insider Relationship	Shares Traded	Average Price	Total Amount	Shares Owned	Filing
2022-05-25 Sale	2022-05-27 7:20 pm	Elevation Oncology Inc.	ELEV	venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. GOODMAN COREY S Adelman Robert J Royston Aaron 10% Owner	702,737	$4.1236	$2,897,806	1,905,430 (Direct)	View
2022-05-13 Sale	2022-05-17 5:12 pm	Checkmate Pharmaceuticals Inc.	CMPI	venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner	131,650	$10.45	$1,375,564	2,155,930 (Direct)	View
2022-05-10 Sale	2022-05-12 8:47 pm	Checkmate Pharmaceuticals Inc.	CMPI	venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner	160,901	$10.39	$1,671,824	2,287,580 (Direct)	View
2022-05-05 Sale	2022-05-09 6:58 pm	Checkmate Pharmaceuticals Inc.	CMPI	venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner	86,677	$10.37	$898,921	2,448,481 (Direct)	View
2022-05-02 Sale	2022-05-04 7:30 pm	Checkmate Pharmaceuticals Inc.	CMPI	venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner	270,675	$10.38	$2,809,332	2,535,158 (Direct)	View
2022-04-27 Sale	2022-04-29 5:50 pm	Checkmate Pharmaceuticals Inc.	CMPI	venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner	190,026	$10.38	$1,972,579	2,805,833 (Direct)	View
2022-04-22 Sale	2022-04-26 6:40 pm	Checkmate Pharmaceuticals Inc.	CMPI	venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner	129,781	$10.39	$1,347,796	2,995,859 (Direct)	View
2022-04-19 Sale	2022-04-21 8:54 pm	Checkmate Pharmaceuticals Inc.	CMPI	venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner	547,734	$10.41	$5,700,491	3,125,640 (Direct)	View
2021-10-22 Sale	2021-10-26 4:35 pm	Metacrine Inc.	MTCR	venBio Global Strategic Fund L.P. venBio Global Strategic GP L.P. venBio Global Strategic GP Ltd. GOODMAN COREY S Adelman Robert J 10% Owner	615,702	$1.5087	$928,902	2,443,421 (Direct)	View
2021-10-25 Purchase	2021-10-25 7:40 pm	Ventyx Biosciences Inc.	VTYX	venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. VENBIO GLOBAL STRATEGIC GP III LTD Adelman Robert J GOODMAN COREY S See Remarks 10% Owner	312,500	$16	$5,000,000	5,011,536 (Indirect Direct)	View
2021-06-29 Purchase	2021-07-01 5:27 pm	Elevation Oncology Inc.	ELEV	venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. GOODMAN COREY S Adelman Robert J Royston Aaron 10% Owner	625,000	$16	$10,000,000	2,608,167 (Direct)	View
2021-04-27 Purchase	2021-04-29 6:44 pm	IMPEL NEUROPHARMA INC	IMPL	venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner	450,000	$15	$6,750,000	2,759,791 (Direct)	View
2020-09-18 Purchase	2020-09-22 5:21 pm	Metacrine Inc.	MTCR	venBio Global Strategic Fund L.P. venBio Global Strategic GP L.P. venBio Global Strategic GP Ltd. GOODMAN COREY S See Remarks 10% Owner	230,000	$13	$2,990,000	3,059,123 (Direct)	View
2020-08-11 Purchase	2020-08-12 9:00 pm	Checkmate Pharmaceuticals Inc.	CMPI	venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner	200,000	$15	$3,000,000	3,673,374 (Direct)	View
2020-07-21 Purchase	2020-07-21 8:01 pm	ALX ONCOLOGY HOLDINGS INC	ALXO	GOODMAN COREY S Executive Chairman 10% Owner	850,000	$19	$16,150,000	515,894 (Indirect)	View
2020-07-01 Sale	2020-07-06 7:00 pm	Akero Therapeutics Inc.	AKRO	venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner	116,467	$34.4	$4,006,537	3,033,552 (Indirect)	View
2020-03-04 Sale	2020-03-06 5:23 pm	Akero Therapeutics Inc.	AKRO	venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner	45,950	$23.76	$1,091,608	3,150,019 (Indirect)	View
2020-02-28 Sale	2020-03-03 5:52 pm	Akero Therapeutics Inc.	AKRO	venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner	21,798	$22.63	$493,310	3,195,969 (Indirect)	View
2020-02-25 Sale	2020-02-27 7:51 pm	Akero Therapeutics Inc.	AKRO	venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner	5,904	$22.8	$134,635	3,227,767 (Indirect)	View
2020-02-10 Sale	2020-02-12 5:56 pm	Akero Therapeutics Inc.	AKRO	venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner	10,026	$27.07	$271,399	3,233,671 (Indirect)	View
2020-02-06 Sale	2020-02-10 5:47 pm	Akero Therapeutics Inc.	AKRO	venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner	6,102	$27.03	$164,955	3,233,697 (Indirect)	View
2020-02-04 Sale	2020-02-06 4:06 pm	Akero Therapeutics Inc.	AKRO	venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner	82,339	$25.77	$2,121,726	3,239,799 (Indirect)	View
2020-01-13 Sale	2020-01-14 08:58 am	Akero Therapeutics Inc.	AKRO	venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner	494,000	$20.23	$9,993,620	3,322,138 (Indirect)	View
2020-01-08 Sale	2020-01-10 4:06 pm	Akero Therapeutics Inc.	AKRO	venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner	15,677	$19.86	$311,355	3,816,138 (Indirect)	View
2020-01-06 Sale	2020-01-08 4:10 pm	Akero Therapeutics Inc.	AKRO	venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner	73,221	$19.86	$1,454,530	3,831,815 (Indirect)	View
2020-01-02 Sale	2020-01-06 4:07 pm	Akero Therapeutics Inc.	AKRO	venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner	35,498	$19.71	$699,721	3,905,036 (Indirect)	View
2019-12-31 Sale	2020-01-03 4:13 pm	Akero Therapeutics Inc.	AKRO	venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner	14,324	$23.96	$343,259	3,940,534 (Indirect)	View
2019-06-24 Purchase	2019-06-25 09:20 am	Akero Therapeutics Inc.	AKRO	venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner	250,000	$16	$4,000,000	3,954,858 (Indirect)	View

Stock options: Exercise, Award, Grant, Conversion

Transaction Date	Reported DateTime	Exercisable Expiration	Company	Symnbol	Insider Relationship	Shares Traded	Conversion Price	Shares Owned	Filing
2022-06-15 Option Award	2022-06-16 8:14 pm	N/A 2032-06-14	ALX ONCOLOGY HOLDINGS INC	ALXO	GOODMAN COREY S Director	12,004	$0	12,004 (Direct)	View
2022-06-09 Option Award	2022-06-10 6:22 pm	N/A 2032-06-09	Ventyx Biosciences Inc.	VTYX	venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. VENBIO GLOBAL STRATEGIC GP III LTD Adelman Robert J GOODMAN COREY S See Remarks 10% Owner	26,602	$0	26,602 (Indirect)	View
2021-10-25 Conversion	2021-10-25 7:40 pm	N/A N/A	Ventyx Biosciences Inc.	VTYX	venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. VENBIO GLOBAL STRATEGIC GP III LTD Adelman Robert J GOODMAN COREY S See Remarks 10% Owner	7,369,538	$0	5,011,536 (Direct)	View
Ownership	2021-10-20 6:45 pm	N/A N/A	Ventyx Biosciences Inc.	VTYX	venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. VENBIO GLOBAL STRATEGIC GP III LTD Adelman Robert J GOODMAN COREY S See Remarks 10% Owner	0	$0	4,699,036 (Indirect)	View
2021-06-29 Conversion	2021-07-01 5:27 pm	N/A N/A	Elevation Oncology Inc.	ELEV	venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. GOODMAN COREY S Adelman Robert J Royston Aaron 10% Owner	10,363,201	$0	2,608,167 (Direct)	View
Ownership	2021-06-24 6:03 pm	N/A N/A	Elevation Oncology Inc.	ELEV	venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. VENBIO GLOBAL STRATEGIC GP III LTD Adelman Robert J GOODMAN COREY S Royston Aaron 10% Owner	0	$0	1,983,167 (Direct)	View
2021-06-11 Option Award	2021-06-15 6:45 pm	N/A 2031-06-10	ALX ONCOLOGY HOLDINGS INC	ALXO	GOODMAN COREY S Director	12,004	$0	12,004 (Direct)	View
2021-04-27 Conversion	2021-04-29 6:44 pm	N/A N/A	IMPEL NEUROPHARMA INC	IMPL	venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner	39,827,381	$0	2,759,791 (Direct)	View
2021-04-22 Other	2021-04-26 7:11 pm	N/A 2021-12-31	IMPEL NEUROPHARMA INC	IMPL	venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner	1,359,799	$0	1,359,799 (Direct)	View
Ownership	2021-04-22 8:05 pm	N/A N/A	IMPEL NEUROPHARMA INC	IMPL	venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner	0	$0	2,208,334 (Direct)	View
2020-09-18 Conversion	2020-09-22 5:21 pm	N/A N/A	Metacrine Inc.	MTCR	venBio Global Strategic Fund L.P. venBio Global Strategic GP L.P. venBio Global Strategic GP Ltd. GOODMAN COREY S See Remarks 10% Owner	5,658,246	$0	3,059,123 (Direct)	View
Ownership	2020-09-15 8:55 pm	N/A N/A	Metacrine Inc.	MTCR	venBio Global Strategic Fund L.P. GOODMAN COREY S venBio Global Strategic GP Ltd. venBio Global Strategic GP L.P. See remarks 10% Owner	0	$0	2,829,123 (Direct)	View
2020-08-11 Conversion	2020-08-12 9:00 pm	N/A N/A	Checkmate Pharmaceuticals Inc.	CMPI	venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner	28,371,348	$0	3,673,374 (Direct)	View
Ownership	2020-08-06 9:03 pm	N/A N/A	Checkmate Pharmaceuticals Inc.	CMPI	venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. GOODMAN COREY S Adelman Robert J 10% Owner	0	$0	3,473,374 (Direct)	View
2020-07-21 Conversion	2020-07-21 8:01 pm	N/A N/A	ALX ONCOLOGY HOLDINGS INC	ALXO	GOODMAN COREY S Executive Chairman 10% Owner	11,224,503	$0	515,894 (Indirect)	View
2020-07-16 Option Award	2020-07-17 7:05 pm	N/A 2030-07-16	ALX ONCOLOGY HOLDINGS INC	ALXO	GOODMAN COREY S Executive Chairman 10% Owner	24,009	$0	24,009 (Direct)	View
Ownership	2020-07-16 6:36 pm	N/A N/A	ALX ONCOLOGY HOLDINGS INC	ALXO	GOODMAN COREY S Executive Chairman 10% Owner	0	$0	7,650,547 (Indirect)	View
2019-06-24 Conversion	2019-06-25 09:20 am	N/A N/A	Akero Therapeutics Inc.	AKRO	venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner	15,094,262	$0	3,954,858 (Indirect)	View
Ownership	2019-06-19 6:58 pm	N/A N/A	Akero Therapeutics Inc.	AKRO	venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner	0	$0	3,704,858 (Indirect)	View

Goto 0, 1, Next

Insider Trading & Ownership - GOODMAN COREY S